Is Ironsail Pharma deep enough for a peptide and longevity clinic?

Ironsail Pharma's multi-pharmacy model is well-suited to longevity clinics precisely because no single 503A pharmacy carries every peptide. Consolidating a long-tail formulary across several compounders into one dashboard is exactly the problem Ironsail Pharma markets against, and that breadth is the headline benefit for a clinic whose protocols span many molecules.

The key thing to confirm is actual catalog depth. Ironsail Pharma does not publish a complete formulary, so a longevity clinic should verify in a demo that the specific peptides it prescribes are available across the partner network — not just the common ones. And because Ironsail Pharma compares prices across its marketplace but does not publish pass-through per-line landed cost, per-item cost is not visible until a sales conversation, which matters when you price specialized protocols.

Longevity ordering hits two pitfalls. First, coverage gaps: a niche peptide that is not in the network forces a workaround that defeats the point of consolidation, so map your full list against the catalog before committing. Second, repeat-ordering friction: when you reorder a wide list often, slow search and no saved favorites turn every restock into a chore, and a protocol that splits pharmacies should still be one cart and one checkout.

Fizy Health is the same multi-pharmacy category but built for breadth and repetition. One catalog shows the full peptide list with resolved per-item 503A cost before checkout, saved favorites speed up repeat ordering, and a multi-line protocol routes from one validated cart even when lines split across compounders. Where Ironsail Pharma publishes no detail, treat it as a demo question rather than an assumption.